These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 2846953
1. Differentiation markers as an aid in the histological diagnosis of small-cell carcinoma of the lung: synopsis of intermediate filament protein and synaptophysin expression. Leube RE, Wiedenmann B, Franke WW. Klin Wochenschr; 1988; 66 Suppl 11():80-6. PubMed ID: 2846953 [Abstract] [Full Text] [Related]
2. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line. Walker C, Wright-Perkins S. Oncol Res; 1992; 4(10):419-29. PubMed ID: 1337994 [Abstract] [Full Text] [Related]
3. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI. Cancer Res; 1990 Sep 15; 50(18):6068-74. PubMed ID: 2168288 [Abstract] [Full Text] [Related]
4. Divergent differentiation in neuroendocrine lung tumors. Brambilla E, Lantuejoul S, Sturm N. Semin Diagn Pathol; 2000 May 15; 17(2):138-48. PubMed ID: 10839614 [Abstract] [Full Text] [Related]
5. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. Westerman BA, Neijenhuis S, Poutsma A, Steenbergen RD, Breuer RH, Egging M, van Wijk IJ, Oudejans CB. Clin Cancer Res; 2002 Apr 15; 8(4):1082-6. PubMed ID: 11948117 [Abstract] [Full Text] [Related]
6. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Lyda MH, Weiss LM. Hum Pathol; 2000 Aug 15; 31(8):980-7. PubMed ID: 10987260 [Abstract] [Full Text] [Related]
7. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma. Liu Y, Sturgis CD, Grzybicki DM, Jasnosz KM, Olson PR, Tong M, Dabbs DD, Raab SS, Silverman JF. Mod Pathol; 2001 Sep 15; 14(9):880-5. PubMed ID: 11557784 [Abstract] [Full Text] [Related]
8. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis. van de Velde HJ, Senden NH, Roskams TA, Broers JL, Ramaekers FC, Roebroek AJ, Van de Ven WJ. Cancer Res; 1994 Sep 01; 54(17):4769-76. PubMed ID: 8062278 [Abstract] [Full Text] [Related]
9. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Blobel GA, Gould VE, Moll R, Lee I, Huszar M, Geiger B, Franke WW. Lab Invest; 1985 Jan 01; 52(1):39-51. PubMed ID: 2981372 [Abstract] [Full Text] [Related]
10. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry. Gould VE, Wiedenmann B, Lee I, Schwechheimer K, Dockhorn-Dworniczak B, Radosevich JA, Moll R, Franke WW. Am J Pathol; 1987 Feb 01; 126(2):243-57. PubMed ID: 3103452 [Abstract] [Full Text] [Related]
11. Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins. Gould VE, Jansson DS, Molenaar WM, Rorke LB, Trojanowski JQ, Lee VM, Packer RJ, Franke WW. Lab Invest; 1990 Apr 01; 62(4):498-509. PubMed ID: 2159086 [Abstract] [Full Text] [Related]
12. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers. Senden NH, Timmer ED, de Bruïne A, Wagenaar SS, Van de Velde HJ, Roebroek AJ, Van de Ven WJ, Broers JL, Ramaekers FC. J Pathol; 1997 May 01; 182(1):13-21. PubMed ID: 9227337 [Abstract] [Full Text] [Related]
13. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors. Ramaekers F, Broers J, Rot MK, Oostendorp T, Wagenaar S, Vooijs P. Acta Histochem Suppl; 1987 May 01; 34():45-56. PubMed ID: 3033739 [Abstract] [Full Text] [Related]
14. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines. Poola I, Graziano SL. J Exp Clin Cancer Res; 1998 Jun 01; 17(2):165-73. PubMed ID: 9700577 [Abstract] [Full Text] [Related]
15. Expression of phosphorylated and non-phosphorylated neurofilament subunits and cytokeratins in neuroendocrine lung tumors. Leoncini P, Bellizzi de Marco E, Bugnoli M, Mencarelli C, Vindigni C, Cintorino M. Pathol Res Pract; 1989 Dec 01; 185(6):848-55. PubMed ID: 2482482 [Abstract] [Full Text] [Related]
16. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines. Banks-Schlegel SP, Gazdar AF, Harris CC. Cancer Res; 1985 Mar 01; 45(3):1187-97. PubMed ID: 2578876 [Abstract] [Full Text] [Related]
17. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Jiang SX, Kameya T, Sato Y, Yanase N, Yoshimura H, Kodama T. Am J Pathol; 1996 Mar 01; 148(3):837-46. PubMed ID: 8774138 [Abstract] [Full Text] [Related]
18. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma. Graff L, Castrop F, Bauer M, Höfler H, Gratzl M. Cancer Res; 2001 Mar 01; 61(5):2138-44. PubMed ID: 11280778 [Abstract] [Full Text] [Related]
19. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E. J Pathol; 2003 Oct 01; 201(2):268-77. PubMed ID: 14517844 [Abstract] [Full Text] [Related]
20. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers. Kasprzak A, Przewoźna M, Surdyk-Zasada J, Zabel M. Folia Morphol (Warsz); 2003 Nov 01; 62(4):497-9. PubMed ID: 14655151 [Abstract] [Full Text] [Related] Page: [Next] [New Search]